Funding for this research was provided by:
Institut Pasteur (024519)
Santé Publique France (024598)
Received: 30 April 2020
Accepted: 15 July 2021
First Online: 30 July 2021
: Invasive <i>H. influenzae</i> isolates were sent to the National Reference Centres for meningococci and <i>Haemophilus influenzae</i> (NRCMHi) as part of national laboratory surveillance systems for invasive bacterial diseases. Residual sera samples were initially received for diagnosis that is part of the routine primary management of suspected invasive bacterial infections. According to the French public health code (Art L1211–2, ExternalRef removed) informed consent (verbal or written) is not required to perform non-genomic analysis on samples. However, the patients and their guardians were informed on the secondary use of their samples for research and they did not oppose to this use. The written form of this non-opposition is sent to our laboratory. Data are anonymised in the database of NRCMHi with no information allowing identifying patients.
: Not applicable.
: All authors declare no competing interests.